Tumors Immunology
It is central to our way of understanding the underlying mechanisms of both tumour rejection and tumour progression. Virtually every known cell type of the immune system is represented in the tumour microenvironment, but as yet the functional significance of intratumoral effector cells is not fully understood. Moreover, the complex interactions between these immune cells within the tumour have yet to be fully elucidated. Although many individual effector cells have the capacity to kill tumour cells in vitro, they are frequently suppressed within the tumour microenvironment through a range of mechanisms. In this article, the known functions of immune effector cells within the tumour and the suppressive processes limiting the function of those cells are described. The Main objectives of the tumour immunology should be to give us a better understanding of how to modify the immune system to fight against cancer. Few of the relevant applications of tumour immunotherapy are described.
Cancer is the major health problem which is bothering worldwide and one of the most important causes of morbidity and mortality in children and adults. The more Effectiveness of malignant tumors is because of their uncontrolled growth of the normal tissues, which in turn cause damage and functional impairment. The malignant phenotype of cancers reflects defects in regulation of cell proliferation, resistance of the tumor cells to apoptotic death, ability of the tumor cells to invade host tissues and metastasize to the innermost layers, of the body and tumor evasion of host immune defense mechanisms.
Related Conference of Tumors Immunology
5th International conference on Vaccines, Vaccination and Immunization
19th International Conference on Allergy and Clinical Immunology
5th International Conference on Immunology And Immunotherapy
Tumors Immunology Conference Speakers
Recommended Sessions
- Antibody Therapies
- Autoimmunity and Allergies
- Cancer immunology
- Clinical immunology
- Computational immunology
- Diagnostic immunology
- Immune Deficiency
- Immunomics
- Immunooncology
- Immunoproteomics
- Immunotherapy
- Immunotoxicology
- Intravascular immunology
- Mucosal immunology
- Neuroimmunology
- Nutritional immunology
- Reproductive immunology
- Stem Cell Immunology
- Systems immunology
- Translational Immunology
- Transplantation Immunology
- Tumors Immunology
- Viral Immunology
- Developmental immunology& Evolutionary immunology
- Ecoimmunology and behavioural immunity
- Immunopathology
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)